Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway

Go back to Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway
(NASDAQ: LEXX) Delayed: 11.51 -0.01 (0.09%)
Previous Close $11.52    52 Week High
Open $11.93    52 Week Low
Day High $11.98    P/E N/A 
Day Low $11.06    EPS
Volume 130,106